N2 Board of Directors

N2 Board of Directors

The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Two seats are assigned to represent networks, 2 seats are assigned to represent institutions, 1 seat is assigned to represent universities, 1 seat is assigned to represent government, 1 seat is assigned to represent the private sector and 4 seats are assigned to represent the membership at large.

The Chair of the Board of Directors is Ms. Karen Arts, one of the co-founders of N2. The Vice-Chair is Ms. Ruth Bullas, from the London Health Sciences Centre. The outgoing Treasurer is Ms. Linda Bennett, co-founder of N2 and Executive Director for the Canadian Rheumatology Research Consortium. The incoming Treasurer is Mr. Patrick Clifford, Director of Research at the Research Institute at Southlake Hospital. The Secretary is Ms Erin Cherban, Director of Clinical Research Operations at the Rick Hansen Institute.

The additional Board members are Mr. Jim Pankovich, Scientific Director of the Canadian HIV Network; Dr Raphael Saginur, Chief Infectious Diseases and Chair Ottawa Hospital REB; Ms. Kathy Brodeur-Robb, Executive Director C-17; Dr. Jeffrey Toward, Continuing Review Manager REB University of British Colombia; and Ms Farida Dabouz, Consultant for the FSRQ. There are currently 2 open positions on the Board.